CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
Marofi F, Saleh MM, Rahman HS, Suksatan W, Al-Gazally ME, Abdelbasset WK, Thangavelu L, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Pathak Y, Naimi A, Baradaran B, Nikoo M, Khiavi FM.
Marofi F, et al.
Stem Cell Res Ther. 2021 Jul 2;12(1):374. doi: 10.1186/s13287-021-02462-y.
Stem Cell Res Ther. 2021.
PMID: 34215336
Free PMC article.
Review.
The tremendous success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells in the treatment of cancer, especially hematological cancers, has exposed CAR's potential. However, the toxicity and significant limitations of CAR-T cell immunotherapy prompted research i …
The tremendous success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells in the treatment of cancer, especially hematological ca …